Closing in on C. difficile infection

Affiliations

Comment

Katrina Ray. Nat Rev Gastroenterol Hepatol. 2019 Oct.

. 2019 Oct;16(10):581.

doi: 10.1038/s41575-019-0206-y.

No abstract available

Comment on

Metabolomic networks connect host-microbiome processes to human Clostridioides difficile infections.
Robinson JI, Weir WH, Crowley JR, Hink T, Reske KA, Kwon JH, Burnham CD, Dubberke ER, Mucha PJ, Henderson JP. Robinson JI, et al. J Clin Invest. 2019 Aug 12;129(9):3792-3806. doi: 10.1172/JCI126905. eCollection 2019 Aug 12. J Clin Invest. 2019. PMID: 31403473 Free PMC article.
Cephamycins inhibit pathogen sporulation and effectively treat recurrent Clostridioides difficile infection.
Srikhanta YN, Hutton ML, Awad MM, Drinkwater N, Singleton J, Day SL, Cunningham BA, McGowan S, Lyras D. Srikhanta YN, et al. Nat Microbiol. 2019 Dec;4(12):2237-2245. doi: 10.1038/s41564-019-0519-1. Epub 2019 Aug 12. Nat Microbiol. 2019. PMID: 31406331

1. Robinson, J. I. et al. Metabolomic networks connect host-microbiome processes to human Clostridiodes difficile infections. J. Clin. Invest. https://doi.org/10.1172/JCI126905 (2019) - DOI - PubMed - PMC
1. Srikhanta, Y. N. et al. Cephamycins inhibit pathogen sporulation and effectively treat recurrent Clostridiodes difficile infection. Nat. Microbiol. https://doi.org/10.1038/s41564-019-0519-1 (2019) - DOI - PubMed